Napyradiomycin B4 | MedChemExpress (MCE)
Napyradiomycin B4 is a Napyradiomycin derivative, which inhibits the RANKL-induced MEK-ERK signaling pathway. Napyradiomycin B4 attenuates osteoclastogenesis and prevents alveolar bone destruction in experimental periodontitis[1].
| Trivial name | Napyradiomycin B4 |
| Catalog Number | HY-N12740 |
| Research Area | Others |
| Purity | ≥98.0% |
| SMILES | Cl[C@](C(C1=C(O)C=C(O)C=C1C2=O)=O)(C[C@H](C(C)(O3)C)Cl)[C@]23C[C@H]4C(C)([C@H](CC[C@@]4(O)C)Cl)C |
| Size | 1 mg |
| Supplier Page | https://www.medchemexpress.com/napyradiomycin-b4.html |